← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 4, 2023Last known activity
Jan 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 7 trials)
Phase 2 (3 own, 0 via acquisition)
Recent trials (22)
- NCT06788132OfficialN/AJan 30, 2025
- NCT06788132Sponsor investigatorN/AJan 30, 2025
- NCT06788132Lead sponsorN/AJan 30, 2025
- NCT06788132CollaboratorN/AJan 30, 2025
- NCT06784024Sponsor investigatorN/AJan 15, 2025
- NCT06784024Lead sponsorN/AJan 15, 2025
- NCT06784024OfficialN/AJan 15, 2025
- NCT06763484OfficialPhase 2Jan 1, 2025
- NCT06759350OfficialN/AJan 1, 2025
- NCT06759350Lead sponsorN/AJan 1, 2025
- NCT06763484Sponsor investigatorPhase 2Jan 1, 2025
- NCT06759350Sponsor investigatorN/AJan 1, 2025
- NCT06763484Lead sponsorPhase 2Jan 1, 2025
- NCT06477770OfficialN/AJun 1, 2024
- NCT06477770Lead sponsorN/AJun 1, 2024
Details
- Last known activity
- Jan 30, 2025